|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4624848A
(en)
|
1984-05-10 |
1986-11-25 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
US4739044A
(en)
|
1985-06-13 |
1988-04-19 |
Amgen |
Method for derivitization of polynucleotides
|
|
US4757141A
(en)
|
1985-08-26 |
1988-07-12 |
Applied Biosystems, Incorporated |
Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
IT1222414B
(it)
|
1987-07-31 |
1990-09-05 |
Chiesi Farma Spa |
Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
|
|
US4843155A
(en)
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
|
IL92966A
(en)
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
AU1537292A
(en)
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
|
US5994056A
(en)
|
1991-05-02 |
1999-11-30 |
Roche Molecular Systems, Inc. |
Homogeneous methods for nucleic acid amplification and detection
|
|
DK0604552T3
(da)
|
1991-09-18 |
1997-08-04 |
Affymax Tech Nv |
Fremgangsmåde til syntese af forskellige samlinger af oligomerer
|
|
JP3195391B2
(ja)
|
1991-11-14 |
2001-08-06 |
エスエス製薬株式会社 |
徐放性トラピジル錠
|
|
US5677195A
(en)
|
1991-11-22 |
1997-10-14 |
Affymax Technologies N.V. |
Combinatorial strategies for polymer synthesis
|
|
AU661080B2
(en)
|
1991-11-22 |
1995-07-13 |
Warner Chilcott Company, Llc |
Risedronate delayed-release compositions
|
|
US5384261A
(en)
|
1991-11-22 |
1995-01-24 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis using mechanically directed flow paths
|
|
US5567583A
(en)
|
1991-12-16 |
1996-10-22 |
Biotronics Corporation |
Methods for reducing non-specific priming in DNA detection
|
|
US5348853A
(en)
|
1991-12-16 |
1994-09-20 |
Biotronics Corporation |
Method for reducing non-specific priming in DNA amplification
|
|
US6033854A
(en)
|
1991-12-16 |
2000-03-07 |
Biotronics Corporation |
Quantitative PCR using blocking oligonucleotides
|
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
IT1255522B
(it)
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
|
KR100291362B1
(ko)
|
1992-10-16 |
2001-09-17 |
니뽄 신야쿠 가부시키가이샤 |
왁스매트릭스의제법
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
CN1087725C
(zh)
*
|
1994-03-25 |
2002-07-17 |
同位素技术有限公司 |
用氘代方法增强药物效果
|
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
|
DE19514048A1
(de)
|
1995-04-13 |
1996-10-17 |
Rentschler Arzneimittel |
Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern
|
|
EP0827402A2
(en)
|
1995-05-17 |
1998-03-11 |
Cedars-Sinai Medical Center |
Compositions containing fatty acids for improving digestion and absorption in the small intestine
|
|
US5545531A
(en)
|
1995-06-07 |
1996-08-13 |
Affymax Technologies N.V. |
Methods for making a device for concurrently processing multiple biological chip assays
|
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
EP0880598A4
(en)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US5869717A
(en)
|
1997-09-17 |
1999-02-09 |
Uop Llc |
Process for inhibiting the polymerization of vinyl aromatics
|
|
AU1287799A
(en)
|
1997-10-31 |
1999-05-24 |
Affymetrix, Inc. |
Expression profiles in adult and fetal organs
|
|
US6020135A
(en)
|
1998-03-27 |
2000-02-01 |
Affymetrix, Inc. |
P53-regulated genes
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
JP2001322933A
(ja)
|
2000-05-15 |
2001-11-20 |
Ucb Sa |
Ｃｄ４０シグナル遮断剤
|
|
US6465014B1
(en)
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
|
US6960563B2
(en)
|
2001-08-31 |
2005-11-01 |
Morton Grove Pharmaceuticals, Inc. |
Spontaneous emulsions containing cyclosporine
|
|
US20060166972A1
(en)
|
2003-07-11 |
2006-07-27 |
Conn P J |
Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
|
|
US20080242657A1
(en)
|
2004-03-26 |
2008-10-02 |
Marino Michael J |
Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists
|
|
DK1957086T3
(en)
|
2005-11-18 |
2018-06-06 |
Cornell Res Foundation Inc |
NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE
|
|
CA2685524A1
(en)
*
|
2007-04-30 |
2008-11-06 |
Abbott Laboratories |
Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
|
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
|
AU2009237570B2
(en)
|
2008-04-18 |
2014-11-06 |
Stephen Dodd |
Magnetic microstructures for magnetic resonance imaging
|
|
KR20140024270A
(ko)
|
2010-12-30 |
2014-02-28 |
파운데이션 메디신 인코포레이티드 |
종양 샘플의 다유전자 분석의 최적화
|
|
US20140045856A1
(en)
|
2012-07-31 |
2014-02-13 |
Boehringer Ingelheim International Gmbh |
4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
|
|
KR101534395B1
(ko)
|
2013-08-01 |
2015-07-09 |
서울대학교산학협력단 |
트라피딜을 유효성분으로 포함하는 골 관련 질환의 예방 또는 치료용 조성물
|
|
WO2017059113A1
(en)
|
2015-09-29 |
2017-04-06 |
Duke University |
Compositions and methods for identifying and treating dystonia disorders
|
|
US11281170B2
(en)
|
2015-12-29 |
2022-03-22 |
Jones And Malterer Technology Innovations Incorporated |
Multi-point synchronizable and scalable lighting control systems
|
|
WO2017176652A2
(en)
*
|
2016-04-04 |
2017-10-12 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using trapidil
|
|
JOP20200187A1
(ar)
*
|
2018-02-02 |
2020-07-29 |
Boehringer Ingelheim Int |
مشتقات ترايازولو بيريميدين للاستخدام كمثبطات جريلين o- أسيل ترانسفيراز (goat)
|
|
CA3163242A1
(en)
|
2019-12-02 |
2021-06-10 |
Aarash BORDBAR |
Treating cognitive disorders using trapidil
|
|
CN115916180A
(zh)
|
2020-03-26 |
2023-04-04 |
希诺皮亚生物科学公司 |
同位素标记的曲匹地尔衍生物
|
|
WO2021262786A1
(en)
|
2020-06-24 |
2021-12-30 |
Yale University |
Pank modulators and methods using same
|